Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Jan 2026, Feb 2026 and Mar 2026.
- Largest single sale: $2.2M (6,958 shares) of Alnylam Pharmaceuticals, Inc. on Feb 13, 2026. Filing
- Last sale before this period: Oct 2, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer, Director | Sep 21, 2016 | Sep 22, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 19, 2026, Alnylam Pharmaceuticals, Inc.: 107 shares awarded. 1 filing: 1
- Mar 4, 2026, Alnylam Pharmaceuticals, Inc.: sold 2,933 shares for $948K, to cover taxes. 1 filing: 1
- Mar 2, 2026, Alnylam Pharmaceuticals, Inc.: sold 6,799 shares for $2.2M, to cover taxes; 13,844 shares granted. 1 filing: 1
- Feb 27, 2026, Alnylam Pharmaceuticals, Inc.: 5,921 shares vested. 1 filing: 1
- Feb 13, 2026, Alnylam Pharmaceuticals, Inc.: sold 6,958 shares for $2.2M, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.